SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-10-000203
Filing Date
2010-02-16
Accepted
2010-02-16 16:04:58
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT adamis-10q_0210.htm 10-Q 551446
2 CERTIFICATION ex31-1.htm EX-31.1 17809
3 CERTIFICATION ex31-2.htm EX-31.2 18535
4 CERTIFICATION ex32-1.htm EX-32.1 6936
5 CERTIFICATION ex32-2.htm EX-32.2 6979
  Complete submission text file 0001387131-10-000203.txt   603215
Mailing Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951
Business Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951 215-529-6084
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26372 | Film No.: 10607626
SIC: 2834 Pharmaceutical Preparations